112 related articles for article (PubMed ID: 8986141)
1. Selective inhibition of cyclooxygenase-1 and -2 using intact insect cell assays.
Cromlish WA; Kennedy BP
Biochem Pharmacol; 1996 Dec; 52(11):1777-85. PubMed ID: 8986141
[TBL] [Abstract][Full Text] [Related]
2. Expression and enzyme activity determination of human cyclooxygenase-1 and -2 in a baculovirus-insect cell system.
Zhang WY; Yang XN; Jin DZ; Zhu XZ
Acta Pharmacol Sin; 2004 Aug; 25(8):1000-6. PubMed ID: 15301731
[TBL] [Abstract][Full Text] [Related]
3. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase.
Gierse JK; Hauser SD; Creely DP; Koboldt C; Rangwala SH; Isakson PC; Seibert K
Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):479-84. PubMed ID: 7832763
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
5. Analysis of prostaglandin G/H synthase-2 inhibition using peroxidase-induced luminol luminescence.
Forghani F; Ouellet M; Keen S; Percival MD; Tagari P
Anal Biochem; 1998 Nov; 264(2):216-21. PubMed ID: 9866686
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.
Laneuville O; Breuer DK; Dewitt DL; Hla T; Funk CD; Smith WL
J Pharmacol Exp Ther; 1994 Nov; 271(2):927-34. PubMed ID: 7965814
[TBL] [Abstract][Full Text] [Related]
8. Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene.
Baek SJ; Wilson LC; Lee CH; Eling TE
J Pharmacol Exp Ther; 2002 Jun; 301(3):1126-31. PubMed ID: 12023546
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibitors of COX-2.
O'Neill GP; Kennedy BP; Mancini JA; Kargman S; Ouellet M; Yergey J; Falgueyret JP; Cromlish WA; Payette P; Chan CC
Agents Actions Suppl; 1995; 46():159-68. PubMed ID: 7610986
[TBL] [Abstract][Full Text] [Related]
10. Investigation of human cyclooxygenase-2 glycosylation heterogeneity and protein expression in insect and mammalian cell expression systems.
Percival MD; Bastien L; Griffin PR; Kargman S; Ouellet M; O'Neill GP
Protein Expr Purif; 1997 Apr; 9(3):388-98. PubMed ID: 9126611
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
Chulada PC; Langenbach R
J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
[TBL] [Abstract][Full Text] [Related]
12. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
Greig GM; Francis DA; Falgueyret JP; Ouellet M; Percival MD; Roy P; Bayly C; Mancini JA; O'Neill GP
Mol Pharmacol; 1997 Nov; 52(5):829-38. PubMed ID: 9351974
[TBL] [Abstract][Full Text] [Related]
13. Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms.
Ouellet M; Percival MD
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):247-51. PubMed ID: 7864817
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation.
Michaluart P; Masferrer JL; Carothers AM; Subbaramaiah K; Zweifel BS; Koboldt C; Mestre JR; Grunberger D; Sacks PG; Tanabe T; Dannenberg AJ
Cancer Res; 1999 May; 59(10):2347-52. PubMed ID: 10344742
[TBL] [Abstract][Full Text] [Related]
15. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor-induced changes in the intrinsic fluorescence of human cyclooxygenase-2.
Houtzager V; Ouellet M; Falgueyret JP; Passmore LA; Bayly C; Percival MD
Biochemistry; 1996 Aug; 35(33):10974-84. PubMed ID: 8718891
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.
Meade EA; Smith WL; DeWitt DL
J Biol Chem; 1993 Mar; 268(9):6610-4. PubMed ID: 8454631
[TBL] [Abstract][Full Text] [Related]
18. PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs.
DeWitt DL; Meade EA; Smith WL
Am J Med; 1993 Aug; 95(2A):40S-44S. PubMed ID: 8357002
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
[TBL] [Abstract][Full Text] [Related]
20. Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: comparison with nonsteroidal anti-inflammatory drugs.
Curnock AP; Robson PA; Yea CM; Moss D; Gadher S; Thomson TA; Westwood R; Ruuth E; Williamson RA
J Pharmacol Exp Ther; 1997 Jul; 282(1):339-47. PubMed ID: 9223572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
